Can NGS Replace Conventional Viral Safety Testing for Cell and Gene Therapy Products?
Meta Intent: A practical, risk-based guide to determining which conventional viral safety assays next-generation sequencing (NGS) may replace, supplement, or leave unchanged across cell and gene therapy manufacturing workflows. Next-generation sequencing (NGS), also called high-throughput sequencing (HTS), detects viral nucleic acids across a broad sequence space without requiring a separate assay for every candidate virus. […]